1.The evaluation value of serum TRPV1,TIMP4 and TGF-β1 levels in predicting recurrence of benign paroxysmal positional vertigo
Lao HU ; Cheng ZHANG ; Zhijun HU
Tianjin Medical Journal 2025;53(3):267-271
Objective To explore the predictive value of serum levels of capsaicin receptor 1(TRPV1),matrix metalloproteinase inhibitor 4(TIMP4)and transforming growth factor beta 1(TGF-β1)for disease recurrence in patients with benign paroxysmal positional vertigo(BPPV).Methods A total of 326 BPPV patients were selected and used as the BPPV group,and 357 healthy individuals who underwent physical examinations during the same period were selected and used as the control group.According to the recurrence status of BPPV patients after 1 year of reduction treatment,patients were divided into the non recurrence group(264 cases)and the recurrence group(62 cases).Enzyme linked immunosorbent assay was used to detect serum levels of TRPV1,TIMP4 and TGF-β1 in patients.Multivariate Logistic regression analysis was performed to analyze influencing factors of recurrence in BPPV patients.Receiver operating characteristic(ROC)curve was used to evaluate the predictive value of TRPV1,TIMP4,and TGF-1 levels for recurrence in BPPV patients.Results TRPV1 and TIMP4 were lower in the BPPV group than those in the control group,while TGF-β1 was higher than that in the control group(P<0.05).The TGF-β1 score in the recurrence group were higher than those in the non recurrence group,while TRPV1 and TIMP4 were lower than those in the non recurrence group(P<0.05).Serum TRPV1 and TIMP4 levels were lower in the recurrence group than those of the non recurrence group,and TGF-1 levels were higher in the recurrence group than those of the non recurrence group(P<0.05).The decreased serum levels of TRPV1 and TIMP4 were risk factors for recurrence in BPPV patients(P<0.05).The area under the curve(AUC)of TRPV1,TIMP4,TGF-β1 and their combined prediction of recurrence in BPPV patients were 0.795(95%CI:0.748-0.838),0.803(95%CI:0.756-0.845),0.810(95%CI:0.764-0.851)and 0.945(95%CI:0.914-0.967),respectively.The combined detection value of TRPV1,TIMP4 and TGF-β1 levels were better than that of single detection in predicting the recurrence in BPPV patients(all P<0.05).Conclusion The serum levels of TRPV1,TIMP4 and TGF-β1 are independent factors affecting the recurrence of BPPV patients,and the combination of the three has a higher predictive value for the recurrence of BPPV patients.
2.Yiqi Huoxue Prescription regulating ferroptosis in endometriosis through MIR-143-3P
Cong SHEN ; Jianting LAO ; Panwei HU ; Hong YANG
International Journal of Traditional Chinese Medicine 2025;47(9):1243-1248
Objective:To explore the mechanism of Yiqi Huoxue Prescription in regulating ferroptosis in endometriosis through MIR-143-3P targeting.Methods:The adherent purification method was used to culture in vitro the isolated endometrial tissue from patients with endometriosis, both in situ and ectopic. The CCK-8 assay was used to detect cell viability. ELISA was used to detect the levels of Fe 2+, MDA, and reduced GSH, and qPCR was used to detect the mRNA expressions of GPX4 and MIR-143-3P. Female SD rats were randomly divided into five groups: sham-operation group, model group, and Yiqi Huoxue Prescription low -, medium -, high - dosage groups, with 8 rats in each group. An endometriosis rat model was established through surgery. Yiqi Huoxue Prescription low-, medium-, and high- dosage groups were administered the solution at dosages of 6.25, 12.5, and 25 g/kg respectively. The sham-operation group and the model group were given the same volume of normal saline. Administration was done twice a day for four consecutive weeks. The volume and weight of ectopic endometrial lesions in rats were measured. HE staining was used to observe pathological changes in the lesions. Levels of Fe 2+, MDA, and GSH were determined. PCR was used to detect GPX4 and MIR-143-3P mRNA levels, and Western blot analysis was used to assess the protein expressions of solute carrier family 7 member 11 (SLC7A11) and GPX4. Results:Compared with the eutopic endometrial cells, the viability of ectopic endometrial cells was enhanced, and the levels of Fe 2+, MDA, and MIR-143-3P mRNA decreased ( P<0.01), while the levels of GSH and GPX4 mRNA increased ( P<0.01). Compared with the model group, the volume and weight of ectopic lesions were reduced in Yiqi Huoxue Prescription high-dosage group ( P<0.01), levels of MIR-143-3P, Fe 2+, and MDA in ectopic lesions were elevated ( P<0.05 or P<0.01), and GSH and GPX4 mRNA levels, as well as the expression levels of SLC7A11 and GPX4 in ectopic lesions, decreased ( P<0.05 or P<0.01). Conclusion:MIR-143-3P is involved in the regulation of ferroptosis in ectopic endometrial cells, and high-dosage Yiqi Huoxue Prescription may promote ferroptosis in ectopic endometrial cells by up-regulating the expression of MIR-143-3P, thereby reducing the ectopic endometrial lesions in endometriosis rats.
3.Expert consensus on the standard of practice for modified electro-convulsive therapy for mental disorders
Xiu ZHANG ; Guohui LAO ; Xiong HUANG ; Wei JIANG ; Qingmei KONG ; Wei LI ; Hu DENG ; Jijun WANG ; Qin XIE ; Wei DENG ; Shaohua HU ; Dongsheng ZHOU ; Xin WEI ; Zhanming SHI ; Cuixia AN ; Sha LIU ; Yanghua TIAN ; Decheng ZOU ; Lingyun ZENG ; Kun LI ; Xingbing HUANG ; Wei ZHENG ; Yuping NING
Chinese Journal of Psychiatry 2025;58(7):506-525
As a physical treatment technique, modified electro-convulsive therapy (MECT) is used to treat mental and certain neurological disorders by causing seizures with short, suitable electrical currents applied to the brain while the patient is under general anesthesia and muscle relaxants. MECT is recognized for its therapeutic efficacy and clinical safety, rendering it one of the most prevalent interventions in psychiatric care. To enhance clinical outcomes and minimize adverse effects, this consensus document delineates the indications, therapeutic parameters, therapeutic procedures, potential adverse effects, and associated management strategies for MECT. These guidelines are informed by the latest clinical research and expert consensus, integrating evidence-based medicine methodologies. The objective is to furnish clinicians with precise operational guidelines and to advance the standardization of MECT practices in clinical settings.
4.Practice of multidrug-resistant organism management under the mode of information reminder system combined with multidisciplinary collaboration
Liyuan QIN ; Shengbin ZHOU ; Qiufeng LAO ; Lingling XIE ; Li'e WANG ; Hong-hong FU ; Peiyun WU ; Jiaguang HU
Chinese Journal of Infection Control 2025;24(11):1641-1646
Objective To explore the application effect of constructing a data sharing-based multidrug-resistant or-ganism(MDRO)information reminder system combined with multidisciplinary standardized measures on the whole-process closed-loop management of MDRO.Methods Hospitalized patients from whom MDRO were detected from January 1 to July 31,2024 were taken as the control group,those from August 1,2024,to May 31,2025 were as the intervention group.The control group adopted the traditional manual reporting mode for MDRO,while the in-tervention group adopted the combination of MDRO reminder system and multidisciplinary management mode.Differences in isolation order issuing rate for MDRO and process-and outcome-indicators for multidisciplinary spe-cialty before and after system implementation were compared.Results After implementing information reminder system combined with multidisciplinary measures,issuing rates of ≤24 hour and<4 hour MDRO isolation orders in the intervention group were both higher than in the control group([90.20%vs 65.23%,P<0.05],[80.64%vs 55.08%,P<0.001],respectively).Antimicrobial use rate in the intervention group was lower than in the con-trol group(36.27%vs 43.41%),with a statistically significant difference(P<0.05).The implementation rates of MDRO prevention and control measures,pathogen detection rates,and fluorescence labeling clearance rates in the intervention group were all higher than those in the control group,all with statistically significant differences(all P<0.05).The detection rate of MDRO decreased compared with the control group(10.83%vs 16.49%),and the in-cidence of MDRO healthcare-associated infection in the intervention group was lower than that in the control group(0.09%vs 0.19%),both with statistically significant differences(both P<0.001).The treatment expense in the intervention group reduced by 27 422 Yuan compared with the control group.Conclusion This study constructed an MDRO reminder system,realized full-chain monitoring system for the multidisciplinary MDRO information interac-tion platform,strengthened multidisciplinary in-depth integration,and improved the prevention and control effect for MDRO.
5.The evaluation value of serum TRPV1,TIMP4 and TGF-β1 levels in predicting recurrence of benign paroxysmal positional vertigo
Lao HU ; Cheng ZHANG ; Zhijun HU
Tianjin Medical Journal 2025;53(3):267-271
Objective To explore the predictive value of serum levels of capsaicin receptor 1(TRPV1),matrix metalloproteinase inhibitor 4(TIMP4)and transforming growth factor beta 1(TGF-β1)for disease recurrence in patients with benign paroxysmal positional vertigo(BPPV).Methods A total of 326 BPPV patients were selected and used as the BPPV group,and 357 healthy individuals who underwent physical examinations during the same period were selected and used as the control group.According to the recurrence status of BPPV patients after 1 year of reduction treatment,patients were divided into the non recurrence group(264 cases)and the recurrence group(62 cases).Enzyme linked immunosorbent assay was used to detect serum levels of TRPV1,TIMP4 and TGF-β1 in patients.Multivariate Logistic regression analysis was performed to analyze influencing factors of recurrence in BPPV patients.Receiver operating characteristic(ROC)curve was used to evaluate the predictive value of TRPV1,TIMP4,and TGF-1 levels for recurrence in BPPV patients.Results TRPV1 and TIMP4 were lower in the BPPV group than those in the control group,while TGF-β1 was higher than that in the control group(P<0.05).The TGF-β1 score in the recurrence group were higher than those in the non recurrence group,while TRPV1 and TIMP4 were lower than those in the non recurrence group(P<0.05).Serum TRPV1 and TIMP4 levels were lower in the recurrence group than those of the non recurrence group,and TGF-1 levels were higher in the recurrence group than those of the non recurrence group(P<0.05).The decreased serum levels of TRPV1 and TIMP4 were risk factors for recurrence in BPPV patients(P<0.05).The area under the curve(AUC)of TRPV1,TIMP4,TGF-β1 and their combined prediction of recurrence in BPPV patients were 0.795(95%CI:0.748-0.838),0.803(95%CI:0.756-0.845),0.810(95%CI:0.764-0.851)and 0.945(95%CI:0.914-0.967),respectively.The combined detection value of TRPV1,TIMP4 and TGF-β1 levels were better than that of single detection in predicting the recurrence in BPPV patients(all P<0.05).Conclusion The serum levels of TRPV1,TIMP4 and TGF-β1 are independent factors affecting the recurrence of BPPV patients,and the combination of the three has a higher predictive value for the recurrence of BPPV patients.
6.Practice of multidrug-resistant organism management under the mode of information reminder system combined with multidisciplinary collaboration
Liyuan QIN ; Shengbin ZHOU ; Qiufeng LAO ; Lingling XIE ; Li'e WANG ; Hong-hong FU ; Peiyun WU ; Jiaguang HU
Chinese Journal of Infection Control 2025;24(11):1641-1646
Objective To explore the application effect of constructing a data sharing-based multidrug-resistant or-ganism(MDRO)information reminder system combined with multidisciplinary standardized measures on the whole-process closed-loop management of MDRO.Methods Hospitalized patients from whom MDRO were detected from January 1 to July 31,2024 were taken as the control group,those from August 1,2024,to May 31,2025 were as the intervention group.The control group adopted the traditional manual reporting mode for MDRO,while the in-tervention group adopted the combination of MDRO reminder system and multidisciplinary management mode.Differences in isolation order issuing rate for MDRO and process-and outcome-indicators for multidisciplinary spe-cialty before and after system implementation were compared.Results After implementing information reminder system combined with multidisciplinary measures,issuing rates of ≤24 hour and<4 hour MDRO isolation orders in the intervention group were both higher than in the control group([90.20%vs 65.23%,P<0.05],[80.64%vs 55.08%,P<0.001],respectively).Antimicrobial use rate in the intervention group was lower than in the con-trol group(36.27%vs 43.41%),with a statistically significant difference(P<0.05).The implementation rates of MDRO prevention and control measures,pathogen detection rates,and fluorescence labeling clearance rates in the intervention group were all higher than those in the control group,all with statistically significant differences(all P<0.05).The detection rate of MDRO decreased compared with the control group(10.83%vs 16.49%),and the in-cidence of MDRO healthcare-associated infection in the intervention group was lower than that in the control group(0.09%vs 0.19%),both with statistically significant differences(both P<0.001).The treatment expense in the intervention group reduced by 27 422 Yuan compared with the control group.Conclusion This study constructed an MDRO reminder system,realized full-chain monitoring system for the multidisciplinary MDRO information interac-tion platform,strengthened multidisciplinary in-depth integration,and improved the prevention and control effect for MDRO.
7.Expert consensus on the standard of practice for modified electro-convulsive therapy for mental disorders
Xiu ZHANG ; Guohui LAO ; Xiong HUANG ; Wei JIANG ; Qingmei KONG ; Wei LI ; Hu DENG ; Jijun WANG ; Qin XIE ; Wei DENG ; Shaohua HU ; Dongsheng ZHOU ; Xin WEI ; Zhanming SHI ; Cuixia AN ; Sha LIU ; Yanghua TIAN ; Decheng ZOU ; Lingyun ZENG ; Kun LI ; Xingbing HUANG ; Wei ZHENG ; Yuping NING
Chinese Journal of Psychiatry 2025;58(7):506-525
As a physical treatment technique, modified electro-convulsive therapy (MECT) is used to treat mental and certain neurological disorders by causing seizures with short, suitable electrical currents applied to the brain while the patient is under general anesthesia and muscle relaxants. MECT is recognized for its therapeutic efficacy and clinical safety, rendering it one of the most prevalent interventions in psychiatric care. To enhance clinical outcomes and minimize adverse effects, this consensus document delineates the indications, therapeutic parameters, therapeutic procedures, potential adverse effects, and associated management strategies for MECT. These guidelines are informed by the latest clinical research and expert consensus, integrating evidence-based medicine methodologies. The objective is to furnish clinicians with precise operational guidelines and to advance the standardization of MECT practices in clinical settings.
8.Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19: A multicenter randomized controlled trial.
Xuan YIN ; Zhu JIN ; Feng LI ; Li HUANG ; Yan-Mei HU ; Bo-Chang ZHU ; Zu-Qing WANG ; Xi-Ying LI ; Jian-Ping LI ; Lixing LAO ; Yi-Qun MI ; Shi-Fen XU
Journal of Integrative Medicine 2024;22(6):637-644
BACKGROUND:
The outbreak of coronavirus disease 2019 (COVID-19) infection posed a huge threat and burden to public healthcare in late 2022. Non-drug measures of traditional Chinese medicine (TCM), such as acupuncture, cupping and moxibustion, are commonly used as adjuncts in China to help in severe cases, but their effects remain unclear.
OBJECTIVES:
To observe the clinical effect of TCM non-drug measures in improving respiratory function and symptoms among patients with severe COVID-19.
DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS:
This study was designed as a multicenter, assessor-blind, randomized controlled trial. Hospitalized patients with COVID-19 were randomly assigned to the treatment or control group. The treatment group received individualized TCM non-drug measures in combination with prone position ventilation, while the control group received prone position ventilation only for 5 consecutive days.
MAIN OUTCOME MEASURES:
The primary outcome measures were the percentage of patients with improved oxygen saturation (SpO2) at the end of the 5-day intervention, as well as changes of patients' respiratory rates. The secondary outcome measures included changes in SpO2 and total score on the self-made respiratory symptom scale. The improvement rate, defined as a 3-day consecutive increase in SpO2, the duration of prone positioning, and adverse events were recorded as well.
RESULTS:
Among the 198 patients included in the intention-to-treat analysis, 159 (80.3%) completed all assessments on day 5, and 39 (19.7%) patients withdrew from the study. At the end of the intervention, 71 (91%) patients in the treatment group had SpO2 above 93%, while 61 (75.3%) in the control group reached this level. The proportion of participant with improved SpO2 was significantly greater in the intervention group (mean difference [MD] = 15.7; 95% confidence interval [CI]: 4.4, 27.1; P = 0.008). Compared to the baseline, with daily treatment there were significant daily decreases in respiratory rates in both groups, but no statistical differences between groups were found (all P ≥ 0.05). Compared to the control group, the respiratory-related symptoms score was lower among patients in the treatment group (MD = -1.7; 95% CI: -2.8, -0.5; P = 0.008) after day 3 of treatment. A gradual decrease in the total scores of both groups was also observed. Thirty-one adverse events occurred during the intervention, and 2 patients were transferred to the intensive care unit due to deterioration of their illness.
CONCLUSION:
TCM non-drug measures combined with prone positioning can effectively treat patients with severe COVID-19. The combined therapy significantly increased SpO2 and improved symptom scores compared to prone positioning alone, thus improving the patients' respiratory function to help them recover. However, the improvement rate did not differ between the two groups.
TRIAL REGISTRATION
Chinese Clinical Trial Registry (ChiCTR2300068319). Please cite this article as: Yin X, Jin Z, Li F, Huang L, Hu YM, Zhu BC, Wang ZQ, Li XY, Li JP, Lao LX, Mi YQ, Xu SF. Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19: A multicenter randomized controlled trial. J Integr Med. 2024; 22(6): 637-644.
Adult
;
Aged
;
Female
;
Humans
;
Male
;
Middle Aged
;
Acupuncture Therapy/methods*
;
China
;
COVID-19/complications*
;
Medicine, Chinese Traditional/methods*
;
Moxibustion/methods*
;
Oxygen Saturation
;
Prone Position
;
Respiration, Artificial
;
Treatment Outcome
9.Research progress on laboratory examination index of clinical prognosis in individualization of cyclosporine A
Jinwei HU ; Huaijun ZHU ; Qianying LAO ; Danying LI
China Pharmacy 2022;33(18):2285-2289
Cyclosporine A is widely used in organ transplantation and autoimmune diseases . Due to the obvious differences in metabolism between individuals ,the dosage should be adjusted according to the patient ’s blood concentration during clinical use . But the blood concentration does not reflect accurately its clinical prognosis . This article focuses on the four laboratory examination indexes following aspects :the cyclosporine A concentration of peripheral blood mononuclear cells ,calcineurin activity ,T cell function and metabolite concentration of cyclosporine A . The relationship between them and the pharmacokinetics of cyclosporine and clinical prognosis were reviewed . It’s found that the above indicators have a certain predictive effect on the clinical prognosis of patients receiving cyclosporine A ,which can make up for the insufficiency of blood drug concentration monitoring ,and the clinical practicability needs to be further improved .
10.Analysis on infectivity of COVID-19 patients before and after last negative nucleic acid test
Yanru CHU ; Yanwu ZHANG ; Song LEI ; Yi CHEN ; Dongliang ZHANG ; Xiaomin GU ; Xuying LAO ; Haibo WANG ; Xiandong SHEN ; Qunxiong HU ; Bo YI ; Enfu CHEN ; Guozhang XU
Chinese Journal of Epidemiology 2022;43(6):841-845
Objective:To investigate the infection rate in close contacts of COVID-19 patients before and after the last negative nucleic acid test, evaluate the effect of dynamic nucleic acid test in determining the infectivity of COVID-19 patients.Methods:Dynamic nucleic acid test results of COVID-19 cases were collected in a retrospective cohort study. COVID-19 cases with negative nucleic acid test results before their first positive nucleic acid tests were selected as study subjects. Close contacts of the index cases and the secondary close contacts were kept isolation for medical observation to assess their risk of infection.Results:This study included 89 confirmed cases from two local COVID-19 epidemics in Ningbo. A total of 5 609 close contacts were surveyed, the overall infection rate was 0.20%. No close contacts of the COVID-19 cases before the last negative nucleic acid test were infected, and the infection rate in the close contacts of the COVID-19 cases after the last negative nucleic acid test was 1.33%, all of these close contacts lived together with the index cases. No secondary close contacts were infected.Conclusion:COVID-19 patient becomes infectious after the last nucleic acid is negative, and has no infectivity before the last nucleic acid negative.

Result Analysis
Print
Save
E-mail